Goldman Sachs Asset Management LP recently announced the acquisition of new stake in Fidelis Insurance Holdings Ltd. (NYSE:FIHL). The institutional investor has increased its shareholding in the Financial company by 0.00% to 15.2 million shares with purchase of 186.0 shares. This fresh investment now brings its stake to 12.08% valued currently at $185.41 million. In addition, American Century Investment Manag raised its holdings by 47528.0 to 2.1 million shares.
With over 0.46 million Fidelis Insurance Holdings Ltd. (FIHL) shares trading Friday and a closing price of $12.81 on the day, the dollar volume was approximately $5.84 million. Currently, there are 116.49M common shares owned by the public and among those 48.24M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Fidelis Insurance Holdings Ltd. are American Century Small Cap Value, CREF Stock Account, and Victory RS Partners Fund. American Century Small Cap Value owns 1.7 million shares of the company’s stock, all valued at over $20.74 million. The company bought an additional 40000.0 shares recently to bring their total holdings to about 1.35% of the shares outstanding. CREF Stock Account bought 0.12 million shares to see its total holdings expand to 0.99 million shares valued at over $12.1 million and representing 0.79% of the shares outstanding. Victory RS Partners Fund bought 0.63 million shares to bring its total holdings to over 0.63 million shares at a value of $7.74 million. Victory RS Partners Fund now owns shares totaling to 0.51% of the shares outstanding.
Shares of Fidelis Insurance Holdings Ltd. (NYSE: FIHL) opened at $12.99, up $0.05 from a prior closing price of $12.94. However, the script later moved the day high at 13.42, down -1.00%. The company’s stock has a 5-day price change of 6.22% and -12.68% over the past three months. It has a 12-month low price of $11.55 and touched a high of $15.30 over the same period. FIHL has an average intraday trading volume of 257.85K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.16%, -3.78%, and -6.91% respectively.
Institutional ownership of Fidelis Insurance Holdings Ltd. (NYSE: FIHL) shares accounts for 26.14% of the company’s 116.49M shares outstanding. Mutual fund holders own 19.62%, while other institutional holders and individual stakeholders account for 4.88% and — respectively.
It has a market capitalization of $1.51B. The company has a debt-to-equity ratio at 0.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.06% over the week and 3.59% over the month.
Analysts forecast that Fidelis Insurance Holdings Ltd. (FIHL) will achieve an EPS of $0.73 for the current quarter, $0.73 for the next quarter and $3.03 for 2024. The lowest estimate earnings-per-share for the quarter is $0.64 while analysts give the company a high EPS estimate of $0.82. Earnings per share for the fiscal year are expected to decrease by -77.34%, and -2.34% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 8 brokerage firm advisors rate Fidelis Insurance Holdings Ltd. (FIHL) as a “Strong Buy” at a consensus score of 1.50. Specifically, 6 Wall Street analysts polled rate the stock as a buy, while 2 of the 8 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the FIHL, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on July 27, 2023, with the firm’s price target at $16.50.
